North Texas Pulmonary & Sleep Disorder Sherman, TX - 75092

North Texas Pulmonary & Sleep Disorder is categorized under Doctors in Sherman, TX and active since 2000.

North Texas Pulmonary & Sleep Disorder was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Allen Salem at the company’s single location by writing to 300 North Highland Avenue # 540, Sherman, Texas TX 75092 or by phoning (814) 267-7491. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: North Texas Pulmonary & Sleep Disorder
Contact Person: Allen Salem
Address: 300 North Highland Avenue # 540, Sherman, Texas 75092
Phone Number: (814) 267-7491
Annual Revenue (USD): $100.000 to $499.999
Founded: 2000
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

North Texas Pulmonary & Sleep Disorder was started in 2000 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Allen Salem for inquiries that concern North Texas Pulmonary & Sleep Disorder by calling the company number (814) 267-7491, as your correspondence is most welcome. Additionally, the physical location of the single location of North Texas Pulmonary & Sleep Disorder can be found at the coordinates 33.636028,-96.62311 as well as the street address 300 North Highland Avenue # 540 in Sherman, Texas 75092.

For its online presence, you may visit North Texas Pulmonary & Sleep Disorder’s website at and engage with its social media outlets through on Twitter and on Facebook.